Targeting Chemokine pathways in esophageal adenocarcinoma

Makardhwaj S. Shrivastava, Zulfiqar Hussain, Orsolya Giricz, Niraj Shenoy, Rahul Polineni, Anirban Maitra, Amit Verma

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Esophageal adenocarcinoma (EAC) is one of the fastest growing malignancies in the US and needs newer therapeutic and diagnostic strategies. Chronic inflammation plays a role in the pathogenesis of EAC and contributes to the dysplastic conversion of normal esophageal epithelium to Barrett's esophagus and frank adenocarcinoma. Chemokines play important roles in mediating inflammation and recent evidence implicates these ligands and their receptors in the development and spread of various tumors. We demonstrated that the chemokines IL8, CXCL1 and CXCL3 are significantly overexpressed during esophageal carcinogenesis and accompanied by amplification and demethylation of the chr4q21 gene locus. We also demonstrated that IL8 levels can be detected in serum of patients with EAC and can serve as potential biomarkers. We now demonstrate that inhibition of IL8 receptor, CXCR2, leads to decreased invasiveness of esophageal adenocarcinoma derived cells without affecting cellular proliferation. Taken together, these studies reveal the important roles that chemokines play in development of esophageal cancer and demonstrate that these pathways can serve as potential therapeutic targets.

Original languageEnglish (US)
Pages (from-to)3320-3327
Number of pages8
JournalCell Cycle
Volume13
Issue number21
DOIs
StatePublished - Nov 1 2014

Fingerprint

Chemokines
Adenocarcinoma
Interleukin-8
Chemokine CXCL1
Interleukin-8 Receptors
Inflammation
Barrett Esophagus
Esophageal Neoplasms
Neoplasms
Carcinogenesis
Epithelium
Biomarkers
Cell Proliferation
Ligands
Therapeutics
Serum
Genes

Keywords

  • Barrett's esophagus
  • Chemokines
  • CXCR2
  • Esophageal adenocarcinoma
  • IL8

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Developmental Biology

Cite this

Shrivastava, M. S., Hussain, Z., Giricz, O., Shenoy, N., Polineni, R., Maitra, A., & Verma, A. (2014). Targeting Chemokine pathways in esophageal adenocarcinoma. Cell Cycle, 13(21), 3320-3327. https://doi.org/10.4161/15384101.2014.968426

Targeting Chemokine pathways in esophageal adenocarcinoma. / Shrivastava, Makardhwaj S.; Hussain, Zulfiqar; Giricz, Orsolya; Shenoy, Niraj; Polineni, Rahul; Maitra, Anirban; Verma, Amit.

In: Cell Cycle, Vol. 13, No. 21, 01.11.2014, p. 3320-3327.

Research output: Contribution to journalArticle

Shrivastava, MS, Hussain, Z, Giricz, O, Shenoy, N, Polineni, R, Maitra, A & Verma, A 2014, 'Targeting Chemokine pathways in esophageal adenocarcinoma', Cell Cycle, vol. 13, no. 21, pp. 3320-3327. https://doi.org/10.4161/15384101.2014.968426
Shrivastava MS, Hussain Z, Giricz O, Shenoy N, Polineni R, Maitra A et al. Targeting Chemokine pathways in esophageal adenocarcinoma. Cell Cycle. 2014 Nov 1;13(21):3320-3327. https://doi.org/10.4161/15384101.2014.968426
Shrivastava, Makardhwaj S. ; Hussain, Zulfiqar ; Giricz, Orsolya ; Shenoy, Niraj ; Polineni, Rahul ; Maitra, Anirban ; Verma, Amit. / Targeting Chemokine pathways in esophageal adenocarcinoma. In: Cell Cycle. 2014 ; Vol. 13, No. 21. pp. 3320-3327.
@article{0c09081d349c4a5084cf87b466c180c5,
title = "Targeting Chemokine pathways in esophageal adenocarcinoma",
abstract = "Esophageal adenocarcinoma (EAC) is one of the fastest growing malignancies in the US and needs newer therapeutic and diagnostic strategies. Chronic inflammation plays a role in the pathogenesis of EAC and contributes to the dysplastic conversion of normal esophageal epithelium to Barrett's esophagus and frank adenocarcinoma. Chemokines play important roles in mediating inflammation and recent evidence implicates these ligands and their receptors in the development and spread of various tumors. We demonstrated that the chemokines IL8, CXCL1 and CXCL3 are significantly overexpressed during esophageal carcinogenesis and accompanied by amplification and demethylation of the chr4q21 gene locus. We also demonstrated that IL8 levels can be detected in serum of patients with EAC and can serve as potential biomarkers. We now demonstrate that inhibition of IL8 receptor, CXCR2, leads to decreased invasiveness of esophageal adenocarcinoma derived cells without affecting cellular proliferation. Taken together, these studies reveal the important roles that chemokines play in development of esophageal cancer and demonstrate that these pathways can serve as potential therapeutic targets.",
keywords = "Barrett's esophagus, Chemokines, CXCR2, Esophageal adenocarcinoma, IL8",
author = "Shrivastava, {Makardhwaj S.} and Zulfiqar Hussain and Orsolya Giricz and Niraj Shenoy and Rahul Polineni and Anirban Maitra and Amit Verma",
year = "2014",
month = "11",
day = "1",
doi = "10.4161/15384101.2014.968426",
language = "English (US)",
volume = "13",
pages = "3320--3327",
journal = "Cell Cycle",
issn = "1538-4101",
publisher = "Landes Bioscience",
number = "21",

}

TY - JOUR

T1 - Targeting Chemokine pathways in esophageal adenocarcinoma

AU - Shrivastava, Makardhwaj S.

AU - Hussain, Zulfiqar

AU - Giricz, Orsolya

AU - Shenoy, Niraj

AU - Polineni, Rahul

AU - Maitra, Anirban

AU - Verma, Amit

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Esophageal adenocarcinoma (EAC) is one of the fastest growing malignancies in the US and needs newer therapeutic and diagnostic strategies. Chronic inflammation plays a role in the pathogenesis of EAC and contributes to the dysplastic conversion of normal esophageal epithelium to Barrett's esophagus and frank adenocarcinoma. Chemokines play important roles in mediating inflammation and recent evidence implicates these ligands and their receptors in the development and spread of various tumors. We demonstrated that the chemokines IL8, CXCL1 and CXCL3 are significantly overexpressed during esophageal carcinogenesis and accompanied by amplification and demethylation of the chr4q21 gene locus. We also demonstrated that IL8 levels can be detected in serum of patients with EAC and can serve as potential biomarkers. We now demonstrate that inhibition of IL8 receptor, CXCR2, leads to decreased invasiveness of esophageal adenocarcinoma derived cells without affecting cellular proliferation. Taken together, these studies reveal the important roles that chemokines play in development of esophageal cancer and demonstrate that these pathways can serve as potential therapeutic targets.

AB - Esophageal adenocarcinoma (EAC) is one of the fastest growing malignancies in the US and needs newer therapeutic and diagnostic strategies. Chronic inflammation plays a role in the pathogenesis of EAC and contributes to the dysplastic conversion of normal esophageal epithelium to Barrett's esophagus and frank adenocarcinoma. Chemokines play important roles in mediating inflammation and recent evidence implicates these ligands and their receptors in the development and spread of various tumors. We demonstrated that the chemokines IL8, CXCL1 and CXCL3 are significantly overexpressed during esophageal carcinogenesis and accompanied by amplification and demethylation of the chr4q21 gene locus. We also demonstrated that IL8 levels can be detected in serum of patients with EAC and can serve as potential biomarkers. We now demonstrate that inhibition of IL8 receptor, CXCR2, leads to decreased invasiveness of esophageal adenocarcinoma derived cells without affecting cellular proliferation. Taken together, these studies reveal the important roles that chemokines play in development of esophageal cancer and demonstrate that these pathways can serve as potential therapeutic targets.

KW - Barrett's esophagus

KW - Chemokines

KW - CXCR2

KW - Esophageal adenocarcinoma

KW - IL8

UR - http://www.scopus.com/inward/record.url?scp=84914694690&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84914694690&partnerID=8YFLogxK

U2 - 10.4161/15384101.2014.968426

DO - 10.4161/15384101.2014.968426

M3 - Article

C2 - 25485576

AN - SCOPUS:84914694690

VL - 13

SP - 3320

EP - 3327

JO - Cell Cycle

JF - Cell Cycle

SN - 1538-4101

IS - 21

ER -